Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Deutsche Forschungsgemeinschaft DFG Atherosclerosis is a chronic inflammatory disease of the arterial wall that causes cardiovascular disease. Monocyte-derived macrophages importantly contribute to atherogenesis. Monocytes can be primed to exhibit increased responsiveness upon a secondary non-related stimulus, a phenomenon called trained immunity. Intracellular metabolic and epigenetic reprogramming lays the basis of trained immunity. One of the stimuli that can induce trained immunity is oxidized low-density lipoprotein (oxLDL). oxLDL-trained monocytes exhibit an increase in metabolic pathways such as glycolysis, OXPHOS, and cholesterol biosynthesis. The glutaminolysis pathway that fuels the tricarboxylic acid (TCA) cycle is essential for trained immunity induction by b-glucan, the cell wall component of Candida albicans. The goal of this project is to investigate the involvement of the glutaminolysis pathway in oxLDL-induced trained immunity in isolated human primary monocytes. We exposed monocytes for 24 hours to oxLDL, allowed subsequent differentiation into macrophages for six days in culture medium, and assessed cytokine production capacity upon restimulation. Co-incubation of oxLDL with the inhibitor that blocks glutaminase, the enzyme that generates glutamate from glutamine, significantly reduced cytokine production capacity in oxLDL-trained cells. We further showed that glutaminolysis is necessary for oxLDL-induced increase in oxygen consumption (OCR) and glycolysis rate (ECAR). Single nucleotide polymorphisms in glutaminolysis genes were shown to correlate with ex vivo oxLDL-induced trained immunity in 243 healthy volunteers. These data suggest an important role of glutaminolysis in the establishment of oxLDL-induced trained immunity. To unravel the molecular mechanisms behind this observation we plan to perform epigenetic as well as metabolic analyses of the monocytes trained in the presence of the inhibitor.

Glutaminolysis and peripheral CD4+ T cell differentiation: from mechanism to intervention strategy

Glutaminolysis of CD4+T Cells: A Potential Therapeutic Target in Viral Diseases

Glutaminolysis of CD4+ T Cells: A Potential Therapeutic Target in Viral Diseases

Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism

Glutaminolysis promotes the function of follicular helper T cells in lupus-prone mice

Glutaminase in Microglia: A Novel Regulator of Neuroinflammation

Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation

Metabolic dynamics instruct CD8<SUP>+</SUP> T-cell differentiation and functions

Metabolic regulation on T cell immune responses

Metabolic Control of gamma delta T Cell Function

A novel differentiation pathway from CD4+ T cells to CD4− T cells for maintaining immune system homeostasis

Mitochondrial Control for Healthy and Autoimmune T Cells

Targeting glutaminolysis pathway in trained immunity induced by oxidized low-density lipoprotein

Glutamine Supplementation Improves the Activity and Immunosuppressive Action of Induced Regulatory T Cells in Vitro and in Vivo

Cellular metabolism regulates the differentiation and function of T-cell subsets

Cellular Metabolic Regulation in the Differentiation and Function of Regulatory T Cells

Metabolism Characteristics of Th17 and Regulatory T Cells in Autoimmune Diseases

Glutaminolysis is required in maintaining immune regulatory functions in B cells

Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells

CD4+ T cell metabolism, gut microbiota, and autoimmune diseases: implication in precision medicine of autoimmune diseases

Glutamine metabolism is essential for the production of IL-17A in γδ T cells and skin inflammation.